九芝堂(000989)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000989 九芝堂

已收盘 03-06 15:00:00

{"stockData":{"symbol":"000989","market":"SZ","secType":"STK","nameCN":"九芝堂","latestPrice":8.69,"timestamp":1772780586000,"preClose":8.5,"halted":0,"volume":6961005,"delay":0,"changeRate":0.0224,"floatShares":694000000,"shares":856000000,"eps":0.1489,"marketStatus":"已收盘","change":0.19,"latestTime":"03-06 15:00:00","open":8.49,"high":8.7,"low":8.45,"amount":59998500,"amplitude":0.0294,"askPrice":8.69,"askSize":1931,"bidPrice":8.68,"bidSize":1941,"shortable":0,"etf":0,"ttmEps":0.1489,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773019800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.5,"symbolType":"stock","openAndCloseTimeList":[[1772760600000,1772767800000],[1772773200000,1772780400000]],"highLimit":9.35,"lowLimit":7.65,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":855942012,"isCdr":false,"pbRate":1.99,"roa":"--","peRate":58.361316,"roe":"4.11%","epsLYR":0.2543,"committee":-0.285159,"marketValue":7438000000,"turnoverRate":0.01,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-09。","floatMarketCap":6032000000},"requestUrl":"/m/hq/s/000989/wiki","defaultTab":"wiki","newsList":[{"id":"2617512966","title":"3月5日九芝堂发生1笔大宗交易 成交金额316万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617512966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617512966?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:13","pubTimestamp":1772702023,"startTime":"0","endTime":"0","summary":"证券之星消息，3月5日九芝堂发生大宗交易，交易数据如下：大宗交易成交价格7.9元，相对当日收盘价折价7.06%，成交40万股，成交金额316万元，买方营业部为民生证券股份有限公司北京第一分公司，卖方营业部为中泰证券股份有限公司杭州湖墅南路证券营业部。近三个月该股共发生2笔大宗交易，合计成交9.02万手，折价成交2笔。截至2026年3月5日收盘，九芝堂报收于8.5元，上涨0.83%，换手率0.72%，成交量5.0万手，成交额4248.4万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500027291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","000989","BK0239","BK0188"],"gpt_icon":0},{"id":"2613279231","title":"九芝堂（000989）披露5%以上股东部分股份解除质押公告，2月24日股价下跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613279231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613279231?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:08","pubTimestamp":1771927698,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，九芝堂报收于8.98元，较前一交易日下跌0.11%，最新总市值为76.86亿元。该股当日开盘9.02元，最高9.07元，最低8.95元，成交额达7854.73万元，换手率为1.26%。近日，九芝堂股份有限公司发布公告称，公司5%以上股东李振国将其持有的18,723,800股公司股份解除质押，占其所持股份比例的12.22%，占公司总股本的2.19%，质权人为黑龙江辰能工大创业投资有限公司。其已质押股份均为高管锁定股，未质押股份中有限售和冻结股份46,517,578股，占未质押股份的59.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400034593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","000989","BK0185"],"gpt_icon":0},{"id":"2610628930","title":"九芝堂：2月9日高管李振国减持股份合计862万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610628930","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610628930?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:01","pubTimestamp":1770728480,"startTime":"0","endTime":"0","summary":"证券之星消息，根据2月10日市场公开信息、上市公司公告及交易所披露数据整理，九芝堂（000989）最新董监高及相关人员股份变动情况：2026年2月9日公司董事,高管李振国共减持公司股份862.0万股，占公司总股本为1.0071%。变动期间公司股价下跌0.97%，2月9日当日收盘报9.16元。九芝堂近半年内的董监高及核心技术人员增减持详情如下：九芝堂的高管列表及最新持股情况如下：该股最近90天内共有1家机构给出评级，买入评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000037126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0140636845.USD","LU1064131003.USD","000989","BK0224","SGXZ49509284.SGD","LU0370786039.SGD","LU0048580855.USD","LU2148510915.USD","LU2328871848.SGD","LU1820825898.SGD","BK0239","LU1997245094.SGD","BK0187","LU2153591404.USD","BK0054","LU1781817850.SGD","LU0326950275.SGD","LU0228659784.USD","601012","LU1242518857.USD","BK0175","LU1146622755.USD","LU0572944931.SGD","LU1997245177.USD","BK0185","LU1969619763.USD","LU1655091616.SGD","LU2348774022.SGD","BK0028","BK0201","LU0327786744.USD","LU1328615791.USD","LU0979878070.USD","BK0196","LU1064130708.USD","SGXZ81163826.USD","BK0188","LU0181495838.USD","LU1580142542.USD","LU2153592121.USD","LU2348773727.SGD","LU2242644610.SGD","LU1242518931.SGD","LU0312595415.SGD"],"gpt_icon":0},{"id":"2610633045","title":"2月9日九芝堂发生1笔大宗交易 成交金额7758万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610633045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610633045?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:25","pubTimestamp":1770629158,"startTime":"0","endTime":"0","summary":"证券之星消息，2月9日九芝堂发生大宗交易，交易数据如下：大宗交易成交价格9元，相对当日收盘价折价1.75%，成交862万股，成交金额7758万元，买方营业部为中国银河证券股份有限公司北京金融街证券营业部，卖方营业部为国泰海通证券股份有限公司北京亮马桥路证券营业部。近三个月该股共发生1笔大宗交易，合计成交8.62万手，折价成交1笔。截至2026年2月9日收盘，九芝堂报收于9.16元，下跌0.97%，换手率3.38%，成交量23.44万手，成交额2.15亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900022057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","000989","BK0239","BK0188"],"gpt_icon":0},{"id":"2606276892","title":"【机构调研记录】富国基金调研九芝堂","url":"https://stock-news.laohu8.com/highlight/detail?id=2606276892","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606276892?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:13","pubTimestamp":1769472822,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及1月26日披露的机构调研信息，富国基金近期对1家上市公司进行了调研，相关名单如下：1）九芝堂 调研纪要：2025年，公司由于受外部环境、市场因素以及内部改革带来的短期调整等综合因素影响，公司部分OTC产品销售收入有所下降，但未出现严重的负面冲击，公司将在一个规范、转型的政策环境中平稳前行。九芝堂美科的人骨髓间充质干细胞注射液治疗孤独症的临床试验已于2025年8月26日召开启动会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700007149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000989","BK0239","BK0185"],"gpt_icon":0},{"id":"2605497327","title":"九芝堂（000989）披露副总经理辞职公告，1月22日股价上涨0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605497327","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605497327?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:26","pubTimestamp":1769091974,"startTime":"0","endTime":"0","summary":"近日，九芝堂股份有限公司发布《关于公司副总经理辞职的公告》。公告显示，2026年1月22日，公司董事会收到副总经理徐向平递交的书面辞职报告，因工作调整申请辞去副总经理职务，辞职后仍继续在公司工作。徐向平原定任期至2027年7月29日，其辞职报告自送达董事会之日起生效。截至公告日，徐向平持有公司股份114,000股，股份将按规定管理，不存在未履行完毕的公开承诺，工作交接将按公司制度进行，辞职不影响公司正常生产经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200040864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0185","000989"],"gpt_icon":0},{"id":"2603609450","title":"九芝堂最新公告：股东李振国拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2603609450","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603609450?lang=zh_cn&edition=full","pubTime":"2026-01-15 19:01","pubTimestamp":1768474862,"startTime":"0","endTime":"0","summary":"九芝堂(000989.SZ)公告称，持股5%以上股东、副董事长、总经理李振国计划自公告披露之日起15个交易日后的3个月内，通过集中竞价或大宗交易方式减持公司股份不超过1,692.56万股，即不超过公司剔除回购专用账户股份后的总股本的2%。减持原因为资金用于偿还到期股权质押融资本金及利息。减持期间为公告披露之日起15个交易日后的3个月内。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500033958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0028","LU1064130708.USD","LU0228659784.USD","LU2148510915.USD","BK0187","LU1997245094.SGD","SGXZ49509284.SGD","BK0239","LU0327786744.USD","000989","LU1655091616.SGD","LU2328871848.SGD","LU0572944931.SGD","LU1242518931.SGD","LU2153591404.USD","LU0370786039.SGD","SGXZ81163826.USD","LU0181495838.USD","LU1820825898.SGD","BK0224","BK0196","LU1242518857.USD","LU2242644610.SGD","LU1328615791.USD","LU2348773727.SGD","LU1146622755.USD","BK0188","BK0201","LU0048580855.USD","LU0140636845.USD","LU1580142542.USD","LU2153592121.USD","BK0054","601012","LU1969619763.USD","LU0979878070.USD","LU0312595415.SGD","BK0175","LU0326950275.SGD","LU2348774022.SGD","LU1997245177.USD","LU1781817850.SGD","LU1064131003.USD"],"gpt_icon":0},{"id":"2594234081","title":"九芝堂：聚焦主业优化产品结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2594234081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594234081?lang=zh_cn&edition=full","pubTime":"2025-12-25 20:51","pubTimestamp":1766667102,"startTime":"0","endTime":"0","summary":"证券之星消息，九芝堂12月24日在投资者关系平台上答复投资者关心的问题。投资者提问：重组方案中上市公司承诺三年业绩扣非净利润之和不低于9亿元，今年前三季度完成1.3亿，同比下滑。公司聚焦主业，以市场需求为导向，持续挖掘产品价值，明晰产品发展方向，不断优化产品结构，深挖渠道潜力，平稳推进创新研发，公司经营及财务情况在定期报告中已进行披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500033370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000989","BK0185","BK0188"],"gpt_icon":0},{"id":"2594234065","title":"九芝堂：下属子公司海南九芝堂药业有限公司注册地为海南省","url":"https://stock-news.laohu8.com/highlight/detail?id=2594234065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594234065?lang=zh_cn&edition=full","pubTime":"2025-12-25 20:51","pubTimestamp":1766667102,"startTime":"0","endTime":"0","summary":"证券之星消息，九芝堂(000989)12月24日在投资者关系平台上答复投资者关心的问题。投资者提问：海南于12月18日封关，这将对海南乃至中国经济产生重大影响，请问公司在海南有哪些布局？九芝堂回复：投资者您好。公司下属子公司海南九芝堂药业有限公司注册地为海南省，其经营及财务状况可查阅公司已对外披露的年度报告及半年度报告。公司持续关注海南相关政策的落地及具体影响，后续如涉及应披露事项，公司将及时履行信息披露义务。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500033375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","000989","BK0239","BK0188"],"gpt_icon":0},{"id":"2589485893","title":"九芝堂（000989）披露对外投资进展公告，12月05日股价上涨0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589485893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589485893?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:46","pubTimestamp":1764927988,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，九芝堂报收于9.26元，较前一交易日上涨0.98%，最新总市值为79.26亿元。公司近日发布公告称，九芝堂股份有限公司第九届董事会第十一次会议审议通过对外投资议案，公司以21,000万元受让哈尔滨吉象隆生物技术有限公司35%股权，并以10,000万元认购其新增注册资本16.6667%股权。交易完成后，公司将持有吉象隆51.6667%股权，吉象隆成为公司控股子公司并纳入合并报表范围。目前吉象隆已完成工商变更登记，并取得新营业执照。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500027669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","000989","BK0185"],"gpt_icon":0},{"id":"2586524121","title":"九芝堂（000989）股东李振国质押1316万股，占总股本1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586524121","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586524121?lang=zh_cn&edition=full","pubTime":"2025-11-27 18:39","pubTimestamp":1764239970,"startTime":"0","endTime":"0","summary":"证券之星消息，九芝堂11月27日公开信息显示，股东李振国向浙商证券股份有限公司合计质押1316.0万股，占总股本1.54%。质押详情见下表：截止本公告日，股东李振国已累计质押股份9363.0万股，占其持股总数的57.83%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700028397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2242644610.SGD","LU0327786744.USD","BK0201","000989","LU0979878070.USD","BK0028","BK0187","LU0326950275.SGD","LU1997245094.SGD","LU2328871848.SGD","LU1655091616.SGD","LU0370786039.SGD","BK0224","LU0312595415.SGD","LU1580142542.USD","LU1997245177.USD","BK0175","SGXZ49509284.SGD","SGXZ81163826.USD","LU1328615791.USD","BK0239","LU2153591404.USD","LU0181495838.USD","LU2348773727.SGD","LU0572944931.SGD","601012","LU0048580855.USD","LU1969619763.USD","LU2148510915.USD","LU1820825898.SGD","LU1242518857.USD","LU1064130708.USD","LU1242518931.SGD","BK0188","BK0196","BK0054","LU0140636845.USD","LU2153592121.USD","LU1146622755.USD","LU1781817850.SGD","BK0185","LU0228659784.USD","LU1064131003.USD","LU2348774022.SGD"],"gpt_icon":0},{"id":"2581911000","title":"九芝堂（000989）披露拟聘任2025年度审计机构，11月06日股价下跌1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581911000","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581911000?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:15","pubTimestamp":1762438521,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，九芝堂报收于9.95元，较前一交易日下跌1.19%，最新总市值为85.17亿元。该股当日开盘10.08元，最高10.08元，最低9.93元，成交额达1.3亿元，换手率为1.88%。九芝堂近日发布公告称，公司于2025年11月6日以通讯方式召开第九届董事会第十二次会议，审议通过了关于选聘公司2025年度审计机构的议案。此外，会议还审议通过了关于召开公司2025年第三次临时股东会的议案，会议定于2025年11月26日召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600038123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0185","000989"],"gpt_icon":0},{"id":"2579211956","title":"九芝堂（000989）披露2025年第三季度报告，10月30日股价上涨0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579211956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579211956?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:12","pubTimestamp":1761819124,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，九芝堂报收于9.96元，较前一交易日上涨0.1%，最新总市值为85.25亿元。九芝堂近日发布《2025年第三季度报告》，披露了公司前三季度主要财务数据。其中，2025年第三季度单季归属于上市公司股东的净利润为7,757,974.26元，同比下降78.30%。资产负债表显示，截至2025年9月30日，公司总资产为4,997,906,547.53元，较上年度末减少4.10%；归属于上市公司股东的所有者权益为3,650,700,089.16元，较上年度末减少2.73%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000036168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000989","BK0185","BK0188"],"gpt_icon":0},{"id":"2579180845","title":"图解九芝堂三季报：第三季度单季净利润同比下降78.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579180845","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579180845?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:18","pubTimestamp":1761765490,"startTime":"0","endTime":"0","summary":"证券之星消息，九芝堂2025年三季报显示，前三季度公司主营收入16.27亿元，同比下降21.13%；归母净利润1.52亿元，同比下降36.94%；扣非净利润1.31亿元，同比下降39.62%；其中2025年第三季度，公司单季度主营收入3.63亿元，同比下降5.51%；单季度归母净利润775.8万元，同比下降78.3%；单季度扣非净利润-502.81万元，同比下降118.77%；负债率22.77%，投资收益2001.09万元，财务费用-188.1万元，毛利率59.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000003198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000989"],"gpt_icon":0},{"id":"2579908453","title":"九芝堂最新公告：拟2.1亿元收购吉象隆生物技术有限公司35%股权并认购其新增注册资本","url":"https://stock-news.laohu8.com/highlight/detail?id=2579908453","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579908453?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:58","pubTimestamp":1761739096,"startTime":"0","endTime":"0","summary":"九芝堂(000989.SZ)公告称，公司与吉象隆生物技术有限公司等签署协议，以2.1亿元受让吉象隆已实缴注册资本769.2435万元，对应35%股权，并以1亿元认购其新增注册资本366.3065万元，对应16.6667%股权。交易完成后，公司将持有吉象隆51.6667%股权，成为其控股股东。同时，吉象隆承诺在2025年至2027年累计净利润不低于1.65亿元，否则将向九芝堂进行补偿。该交易不涉及关联交易，也不构成重大资产重组。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000989","BK0185","BK0188"],"gpt_icon":0},{"id":"2518743285","title":"ST九芝(000989.SZ)子公司北京美科研发新药获得临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2518743285","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518743285?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:22","pubTimestamp":1741695721,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST九芝(000989.SZ)公告，公司控股子公司九芝堂美科(北京)细胞技术有限公司(简称“北京美科”)研发的新药人骨髓间充质干细胞注射液近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意开展治疗孤独症的临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","BK1576","BK1583","000989","BK0239","BK0188","BK1141","03347"],"gpt_icon":0},{"id":"2518374394","title":"ST九芝最新公告：控股子公司新药获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2518374394","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518374394?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:09","pubTimestamp":1741694961,"startTime":"0","endTime":"0","summary":"ST九芝(000989.SZ)公告称，公司控股子公司九芝堂美科（北京）细胞技术有限公司研发的人骨髓间充质干细胞注射液近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意开展治疗孤独症的临床试验。该药物属于治疗用生物制品1类，目前主要通过康复训练、心理治疗和家庭干预等综合措施来改善患者的症状和提高生活质量。由于药物研发的特殊性，从临床试验到投产上市的周期长、环节多，易受到诸多不可预测的因素影响，临床试验进度及结果、未来产品市场竞争形势均存在诸多不确定性。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100037626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000989","BK0188","BK0239","BK1583","BK1576","BK1141","03347","BK0185"],"gpt_icon":0},{"id":"2518720215","title":"ST九芝获得发明专利授权：“一种微波高压电源冷却系统”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720215","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518720215?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:14","pubTimestamp":1741634075,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示ST九芝新获得一项发明专利授权，专利名为“一种微波高压电源冷却系统”，专利申请号为CN201910551661.6，授权日为2025年3月11日。专利摘要：本发明公开了一种微波高压电源冷却系统，包括电源安装管道1、空调机组2、进风管道3、进风口4、出风管道5、出风口6、新风管道7、新风口8及直膨式空调机组排水管9。今年以来ST九芝新获得专利授权1个，与去年同期持平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100003338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","000989","BK0185"],"gpt_icon":0},{"id":"2509409104","title":"ST九芝(000989.SZ)：累计回购1.13%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2509409104","media":"格隆汇","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509409104?lang=zh_cn&edition=full","pubTime":"2025-02-05 19:08","pubTimestamp":1738753715,"startTime":"0","endTime":"0","summary":"格隆汇2月5日丨ST九芝(000989.SZ)公布，截至2025年1月31日，公司通过回购专用证券账户以集中竞价交易方式累计回购公司股份9,660,000股，占公司目前总股本的1.13%，最高成交价为8.21元/股，最低成交价为7.50元/股，成交总金额为人民币76,200,959.71元（不含交易费用）。本次回购股份的资金来源为公司自有资金，回购价格未超过回购方案中拟定的价格上限。公司回购股份的实施符合相关法律法规的要求，符合公司既定的回购方案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/05190847964057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000989","BK0188","BK0185","BK0239"],"gpt_icon":0},{"id":"2509140668","title":"ST九芝(000989.SZ)：新药注射用咔喏霉素获得临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2509140668","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509140668?lang=zh_cn&edition=full","pubTime":"2025-02-05 18:54","pubTimestamp":1738752889,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST九芝(000989.SZ)发布公告，公司全资子公司牡丹江友搏药业有限责任公司(以下简称“友搏药业”)研发的新药注射用咔喏霉素(即YB211项目)近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意开展II期临床试验。该临床试验方案：以注射用达托霉素为对照，初步探索静脉输注不同剂量的YB211治疗成人急性细菌性皮肤及皮肤结构感染受试者的有效性和安全性的随机、盲法、阳性药平行对照、多中心的II期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1246161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0185","BK0188","03347","BK1141","000989","BK1576","BK1583"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772820205453,"stockEarnings":[{"period":"1week","weight":-0.0355},{"period":"1month","weight":-0.0192},{"period":"3month","weight":-0.0616},{"period":"6month","weight":-0.1879},{"period":"1year","weight":0.0935},{"period":"ytd","weight":-0.0046}],"compareEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"九芝堂股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"57358人(较上一季度增加13.53%)","perCapita":"12102股","listingDate":"2000-06-28","address":"湖南省长沙市岳麓区高新区桐梓坡西路339号","registeredCapital":"85594万元","survey":"　　九芝堂股份有限公司的主营业务是以中药研发、生产和销售等业务为核心，逐步探索布局干细胞、中医医疗健康服务、药食同源系列产品等创新业务。公司的主要产品是OTC类、处方药类、大健康类。公司是国家重点高新技术企业、国家级创新型试点企业、国家中医药管理局中医药工程学重点学科建设单位、国家企业技术中心、国家知识产权示范企业。","listedPrice":9},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九芝堂(000989)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九芝堂(000989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九芝堂,000989,九芝堂股票,九芝堂股票老虎,九芝堂股票老虎国际,九芝堂行情,九芝堂股票行情,九芝堂股价,九芝堂股市,九芝堂股票价格,九芝堂股票交易,九芝堂股票购买,九芝堂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九芝堂(000989)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九芝堂(000989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}